Nina S. Iversen

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Risk stratification according to genotype and effect of thromboprophylaxis on obstetric outcomes in women with antithrombin deficiency.

Risk stratification according to genotype and effect of thromboprophylaxis on obstetric outcomes in women with antithrombin deficiency.

Journal: Research and practice in thrombosis and haemostasis
Published: August 25, 2025

Characterization of a novel factor X variant, p.F139L, associated with bleedings in heterozygous and compound heterozygous form.

Characterization of a novel factor X variant, p.F139L, associated with bleedings in heterozygous and compound heterozygous form.

Journal: Thrombosis research
Published: May 22, 2025

Ex vivo correction of severe coagulation Factor VII deficiency in patient-derived 3D liver organoids.

Ex vivo correction of severe coagulation Factor VII deficiency in patient-derived 3D liver organoids.

Journal: Haematologica
Published: April 23, 2025

Functional and Regulatory Effects of Factor V Leiden and Factor V rs6028 in Breast Cancer.

Functional and Regulatory Effects of Factor V Leiden and Factor V rs6028 in Breast Cancer.

Journal: Genes
Published: April 14, 2025

Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study.

Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study.

Journal: Journal of thrombosis and haemostasis : JTH
Published: June 20, 2024

Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava.

Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava.

Journal: Thrombosis journal
Published: April 15, 2024

Elevated TFPI is a prognostic factor in hepatocellular carcinoma: Putative role of miR-7-5p and miR-1236-3p.

Elevated TFPI is a prognostic factor in hepatocellular carcinoma: Putative role of miR-7-5p and miR-1236-3p.

Journal: Thrombosis research
Published: March 21, 2024

The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.

The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.

Journal: Journal of thrombosis and haemostasis : JTH
Published: August 23, 2023

Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy.

Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 26, 2023

Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.

Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.

Journal: BMC cancer
Published: January 25, 2023

Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells.

Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells.

Journal: Thrombosis and haemostasis
Published: November 26, 2021

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.

Journal: Blood
Published: November 08, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026